Medtronic 2012 Annual Report Download - page 19

Download and view the complete annual report

Please find page 19 of the 2012 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 152

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152

CARDIAC AND VASCULAR GROUP
Cardiac Rhythm Disease Management
CRDM develops, manufactures, and markets products for the diagnosis, treatment, and management
of heart rhythm disorders and heart failure, including implantable devices, leads and delivery systems,
products for the treatment of atrial fibrillation (AF), and information systems for the management of
patients with CRDM devices.
The following are the principal products offered by our CRDM business:
Implantable Cardiac Pacemakers (Pacemakers). A pacemaker is a battery-powered device
implanted in the chest that delivers electrical impulses to treat bradycardia, a condition of abnormally slow
heart rhythms, usually less than 60 beats per minute, or unsteady heart rhythms that cause symptoms such
as dizziness, fainting, fatigue, and shortness of breath. Our latest generation of pacemaker systems is
compatible with certain magnetic resonance imaging (MRI) machines. This includes the Revo MRI
SureScan with United States (U.S.) Food and Drug Administration (U.S. FDA) approval and the Advisa and
Ensura MRI SureScan models with Conformite Europeene (CE) Mark approval. Medtronic also continues
to market the Adapta product family, which includes the Adapta, Versa, Sensia, and Relia models.
Implantable Cardioverter Defibrillators (ICDs). An ICD continually monitors the heart and delivers
therapy when an abnormal heart rhythm, such as tachyarrhythmia, or rapid heart rhythm, occurs and leads
to sudden cardiac arrest. The latest generation of Medtronic ICDs is the Protecta family with SmartShock
technology, including the Lead Integrity Alert, an exclusive technology designed to improve the detection
of lead fractures. Devices in the ICD family are the Protecta XT, Protecta, Cardia, and Egida models.
Medtronic also continues to market the Secura and Maximo II devices. Medtronic ICDs are designed to
work with the Sprint Quattro defibrillation leads.
Implantable Cardiac Resynchronization Therapy Devices (CRT-Ds and CRT-Ps). Implantable
cardiac resynchronization therapy devices are combined with defibrillation (CRT-D) or are pacing-only
(CRT-P). These devices treat heart failure patients by altering the abnormal electrical sequence of cardiac
contractions by sending tiny electrical impulses to the lower chambers of the heart to help them beat in a
more synchronized fashion. The latest generation of Medtronic CRT-Ds is the Protecta family with
SmartShock technology, including Protecta XT and Protecta, and the latest CRT-P devices are Consulta
and Syncra. Medtronic also continues to market the Consulta, Cardia, Egida, and Maximo II CRT-D
devices. In addition to these devices, Medtronic has a unique offering of left heart leads and delivery
catheters with its Attain family of products.
AF Products. AF is a condition in which the atrium quivers instead of pumping blood effectively.
Our portfolio of AF products includes the Arctic Front Cardiac CryoAblation Catheter designed specifically
to treat paroxysmal AF by performing pulmonary vein isolation. Additionally, we have a CE Mark approved
portfolio of anatomically-shaped ablation catheters that use a duty cycled, phased radio frequency energy
system for the treatment of permanent and persistent AF. These products are currently being evaluated by
the U.S. FDA. We also offer the Reveal XT Insertable Cardiac Monitor, which is designed to identify and
quantify episodes of AF.
Diagnostics and Monitoring Devices. The Reveal DX and Reveal XT Insertable Cardiac Monitors
are small, memory-stick sized devices that are placed under the skin and can continuously monitor the heart.
The devices are used to record the heart’s electrical activity before, during, and after transient symptoms
such as syncope (i.e., fainting) and palpitations to help provide a diagnosis. The latest generation product,
Reveal XT, adds the capability to detect AF and provides long-term trending information to help inform the
ongoing management of AF.
Patient Management Tools. We have a number of patient management tools, such as CareLink,
Paceart, and CardioSight Service. CareLink enables patients to transmit data from their pacemaker, ICD,
CRT-D, or Insertable Cardiac Monitors using a portable monitor that is connected to a standard telephone
line or cellular network using the Medtronic M-Link accessory. Paceart organizes and archives data for
cardiac devices from major device manufacturers, serving as the central hub for patients’ device data.
CardioSight Service is an in-clinic data access tool available to physicians treating heart failure patients
who have one of several types of Medtronic CRT-Ds or ICDs.
2